Circulating CD3⁺CD4⁺CD161⁺ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma

Figure 2

Multivariate analyses including clinical risk factors showing the predictive role of the proportion of pretransplant CD3⁺CD4⁺CD161⁺ cells for (a) the occurrence of mucositis (≥grade 3) and (b) infection before engraftment.

(a)

(b)